[go: up one dir, main page]

IL108443A0 - C7 taxane derivatives and pharmaceutical compositions containing them - Google Patents

C7 taxane derivatives and pharmaceutical compositions containing them

Info

Publication number
IL108443A0
IL108443A0 IL10844394A IL10844394A IL108443A0 IL 108443 A0 IL108443 A0 IL 108443A0 IL 10844394 A IL10844394 A IL 10844394A IL 10844394 A IL10844394 A IL 10844394A IL 108443 A0 IL108443 A0 IL 108443A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
taxane derivatives
derivatives
taxane
Prior art date
Application number
IL10844394A
Other languages
English (en)
Original Assignee
Univ Florida State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/010,798 external-priority patent/US5399726A/en
Application filed by Univ Florida State filed Critical Univ Florida State
Publication of IL108443A0 publication Critical patent/IL108443A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/87Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/60Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
    • C07C2603/62Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing three- or four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL10844394A 1993-01-29 1994-01-26 C7 taxane derivatives and pharmaceutical compositions containing them IL108443A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/010,798 US5399726A (en) 1993-01-29 1993-01-29 Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
US3485293A 1993-03-22 1993-03-22
US9516093A 1993-07-20 1993-07-20

Publications (1)

Publication Number Publication Date
IL108443A0 true IL108443A0 (en) 1994-04-12

Family

ID=27359310

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10844394A IL108443A0 (en) 1993-01-29 1994-01-26 C7 taxane derivatives and pharmaceutical compositions containing them

Country Status (12)

Country Link
EP (3) EP1108717B1 (fr)
JP (2) JPH08506324A (fr)
AT (3) ATE236142T1 (fr)
AU (1) AU689099B2 (fr)
CA (1) CA2155018C (fr)
DE (3) DE69434861T2 (fr)
DK (3) DK1275389T3 (fr)
ES (3) ES2191029T3 (fr)
IL (1) IL108443A0 (fr)
PT (3) PT1275389E (fr)
TW (1) TW492963B (fr)
WO (1) WO1994017050A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721268A (en) * 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5710287A (en) 1991-09-23 1998-01-20 Florida State University Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
FR2712289B1 (fr) * 1993-11-08 1996-01-05 Rhone Poulenc Rorer Sa Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5677470A (en) * 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
US6500858B2 (en) 1994-10-28 2002-12-31 The Research Foundation Of The State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US6458976B1 (en) 1994-10-28 2002-10-01 The Research Foundation Of State University Of New York Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
WO1996013495A1 (fr) * 1994-10-28 1996-05-09 The Research Foundation Of State University Of New York Derives taxoides, leur preparation et leur utilisation en tant qu'agents antitumoraux
CA2162759A1 (fr) * 1994-11-17 1996-05-18 Kenji Tsujihara Derives de la baccatine et methodes de preparation
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
EP0868422A1 (fr) * 1996-09-24 1998-10-07 Marigen S.A. Ultramicroemulsions constituees de concentres pouvant etre disperses de fa on spontanne, renfermant des esters de composes de baccatine-iii a effet antitumoral et antiviral
AR030188A1 (es) * 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
HUP0200651A3 (en) * 2000-02-02 2002-10-28 Univ Florida State Res Found C7 heterosubstituted acetate taxanes as antitumor agents and pharmaceutical compositions containing them
PL202957B1 (pl) * 2000-02-02 2009-08-31 Univ Florida State Res Found Podstawione grupą estrową C10 taksany, kompozycja farmaceutyczna zawierająca te związki i zastosowanie tych związków do wytwarzania leku
US6362217B2 (en) 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
JP2005539009A (ja) 2002-08-02 2005-12-22 イミュノジェン・インコーポレーテッド 新規の効力のあるタキサンを含む細胞毒性物質、および、それらの治療用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
JP3304088B2 (ja) * 1991-09-23 2002-07-22 フロリダ・ステイト・ユニバーシティ 10−デスアセトキシタキソール誘導体
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5248796A (en) * 1992-06-18 1993-09-28 Bristol-Myers Squibb Company Taxol derivatives
CA2100808A1 (fr) * 1992-10-01 1994-04-02 Vittorio Farina Desoxytaxols
IL108316A (en) * 1993-01-15 2006-10-31 Univ Florida State History of C-10 Texan and pharmaceuticals containing them
IL108444A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C2 taxane derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP1108717A2 (fr) 2001-06-20
DE69432835T2 (de) 2004-04-22
DE69434861D1 (de) 2006-11-16
EP0681574A1 (fr) 1995-11-15
DE69432404T2 (de) 2003-10-30
ATE341321T1 (de) 2006-10-15
DK1108717T3 (da) 2003-10-13
JP3940392B2 (ja) 2007-07-04
EP0681574A4 (fr) 1995-12-13
EP1275389A1 (fr) 2003-01-15
EP0681574B1 (fr) 2003-04-02
PT1108717E (pt) 2003-11-28
ATE236142T1 (de) 2003-04-15
ES2267921T3 (es) 2007-03-16
JP2004043499A (ja) 2004-02-12
CA2155018A1 (fr) 1994-08-04
EP1275389B1 (fr) 2006-10-04
ES2199901T3 (es) 2004-03-01
ES2191029T3 (es) 2003-09-01
PT681574E (pt) 2003-09-30
EP1108717A3 (fr) 2001-08-29
JPH08506324A (ja) 1996-07-09
DK1275389T3 (da) 2007-02-12
CA2155018C (fr) 2006-11-28
WO1994017050A1 (fr) 1994-08-04
DE69432404D1 (de) 2003-05-08
AU6233794A (en) 1994-08-15
EP1108717B1 (fr) 2003-06-18
DE69434861T2 (de) 2007-04-26
DK0681574T3 (da) 2003-07-28
TW492963B (en) 2002-07-01
DE69432835D1 (de) 2003-07-24
PT1275389E (pt) 2006-12-29
ATE243205T1 (de) 2003-07-15
AU689099B2 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
IL108443A0 (en) C7 taxane derivatives and pharmaceutical compositions containing them
IL110660A0 (en) Phosphonooxymethyl ethers of taxane derivatives
DE69716135D1 (en) In 6-position durch thio substituierte paclitaxele
BG102172A (en) New stable medicamentous compositions for the preparation of propellant-free aerosols
NZ514409A (en) C7 ester substituted taxanes as antitumor agents
MY113806A (en) Antiparasitic marcfortines and paraherquamides
AP2004003103A0 (en) Controlled synthesis of ziprasidone and compositions thereof
SI0889886T1 (en) Novel phenanthridines substituted in the 6 position
DE69715173D1 (en) Bisarylcyclobutenderivate als cyclooxygenasehemmer
IL107555A0 (en) Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
IL108444A0 (en) C2 taxane derivatives and pharmaceutical compositions containing them
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
DK0688212T3 (da) C9-taxanderivater og farmaceutiske præparater indeholdende disse
EP1011329A4 (fr) Paclitaxels 7-methylthiooxomethyle et 7-methylthiodioxomethyle
IL145643A0 (en) C7 carbamoyloxy substituted taxanes as antitumor agents
ATE223427T1 (de) Modifizierte kojibioside analoge
IL109049A0 (en) Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
EP1108716A3 (fr) Dérivés de taxanne en C7 et compositions pharmaceutiques les contenant
TWI226833B (en) Pharmaceutical composition for inhibiting bone resorption